

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 7.58344200 |
| 2 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 7.04048496 |
| 3 | artery development (GO:0060840) | 6.82200562 |
| 4 | lung lobe morphogenesis (GO:0060463) | 6.82074633 |
| 5 | transepithelial transport (GO:0070633) | 6.80777904 |
| 6 | prostate gland epithelium morphogenesis (GO:0060740) | 6.64459510 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 6.57832773 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 6.57832773 |
| 9 | fucose catabolic process (GO:0019317) | 6.28023184 |
| 10 | L-fucose metabolic process (GO:0042354) | 6.28023184 |
| 11 | L-fucose catabolic process (GO:0042355) | 6.28023184 |
| 12 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.92773145 |
| 13 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 5.90578666 |
| 14 | mannose metabolic process (GO:0006013) | 5.85612248 |
| 15 | mitotic cell cycle arrest (GO:0071850) | 5.58305063 |
| 16 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 5.55981762 |
| 17 | response to testosterone (GO:0033574) | 5.43924006 |
| 18 | N-glycan processing (GO:0006491) | 5.39380735 |
| 19 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.33950424 |
| 20 | positive regulation of steroid hormone secretion (GO:2000833) | 5.31513446 |
| 21 | regulation of receptor binding (GO:1900120) | 5.29784544 |
| 22 | intestinal epithelial cell development (GO:0060576) | 5.26636518 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 5.14240282 |
| 24 | galactose catabolic process (GO:0019388) | 5.12166508 |
| 25 | fucose metabolic process (GO:0006004) | 4.93105122 |
| 26 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.90643720 |
| 27 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.88935111 |
| 28 | positive regulation of astrocyte differentiation (GO:0048711) | 4.83658773 |
| 29 | epithelial cell maturation (GO:0002070) | 4.72158907 |
| 30 | negative regulation of complement activation (GO:0045916) | 4.71193345 |
| 31 | protein retention in ER lumen (GO:0006621) | 4.69899026 |
| 32 | positive regulation of nuclease activity (GO:0032075) | 4.68125203 |
| 33 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.61574782 |
| 34 | angiotensin maturation (GO:0002003) | 4.55097088 |
| 35 | valine metabolic process (GO:0006573) | 4.44164245 |
| 36 | hormone catabolic process (GO:0042447) | 4.40912726 |
| 37 | positive regulation of growth hormone secretion (GO:0060124) | 4.38081363 |
| 38 | hypotonic response (GO:0006971) | 4.29418397 |
| 39 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.24254806 |
| 40 | regulation of nuclease activity (GO:0032069) | 4.21713677 |
| 41 | lung secretory cell differentiation (GO:0061140) | 4.13709332 |
| 42 | negative regulation of protein activation cascade (GO:2000258) | 4.13617735 |
| 43 | cellular response to unfolded protein (GO:0034620) | 4.10429186 |
| 44 | tight junction assembly (GO:0070830) | 4.08641224 |
| 45 | L-serine transport (GO:0015825) | 4.03790692 |
| 46 | hepatocyte apoptotic process (GO:0097284) | 3.98036642 |
| 47 | apoptotic cell clearance (GO:0043277) | 3.97723288 |
| 48 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.95302036 |
| 49 | decidualization (GO:0046697) | 3.92783437 |
| 50 | ER-nucleus signaling pathway (GO:0006984) | 3.90655830 |
| 51 | histamine secretion (GO:0001821) | 3.89407819 |
| 52 | response to endoplasmic reticulum stress (GO:0034976) | 3.88960953 |
| 53 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.88750895 |
| 54 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.82227220 |
| 55 | negative regulation of humoral immune response (GO:0002921) | 3.81753236 |
| 56 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.81359826 |
| 57 | cellular response to topologically incorrect protein (GO:0035967) | 3.80655156 |
| 58 | histamine transport (GO:0051608) | 3.80080514 |
| 59 | membrane budding (GO:0006900) | 3.79841322 |
| 60 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.78313113 |
| 61 | pharyngeal system development (GO:0060037) | 3.77088731 |
| 62 | nephron tubule formation (GO:0072079) | 3.76879647 |
| 63 | COPII vesicle coating (GO:0048208) | 3.75598579 |
| 64 | protein autoprocessing (GO:0016540) | 3.74545774 |
| 65 | interferon-gamma secretion (GO:0072643) | 3.72504957 |
| 66 | cell adhesion mediated by integrin (GO:0033627) | 3.72119123 |
| 67 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.66651905 |
| 68 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.66155426 |
| 69 | positive regulation of odontogenesis (GO:0042482) | 3.61899487 |
| 70 | hexose catabolic process (GO:0019320) | 3.61406313 |
| 71 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.61400860 |
| 72 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.56675123 |
| 73 | regulation of alkaline phosphatase activity (GO:0010692) | 3.56496559 |
| 74 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.56010882 |
| 75 | hemidesmosome assembly (GO:0031581) | 3.53965872 |
| 76 | positive regulation of extracellular matrix organization (GO:1903055) | 3.51740473 |
| 77 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.51136213 |
| 78 | cellular extravasation (GO:0045123) | 3.50056736 |
| 79 | serine transport (GO:0032329) | 3.49895974 |
| 80 | peptidyl-asparagine modification (GO:0018196) | 3.48950392 |
| 81 | regulation of growth hormone secretion (GO:0060123) | 3.47892997 |
| 82 | regulation of steroid hormone secretion (GO:2000831) | 3.46712701 |
| 83 | vitamin transmembrane transport (GO:0035461) | 3.46241189 |
| 84 | skin morphogenesis (GO:0043589) | 3.43447845 |
| 85 | membrane raft organization (GO:0031579) | 3.43225547 |
| 86 | regulation of protein glycosylation (GO:0060049) | 3.40154865 |
| 87 | sulfur amino acid catabolic process (GO:0000098) | 3.38400547 |
| 88 | beta-amyloid metabolic process (GO:0050435) | 3.38286245 |
| 89 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.34003922 |
| 90 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.33987201 |
| 91 | vesicle coating (GO:0006901) | 3.32372569 |
| 92 | protein heterotetramerization (GO:0051290) | 3.32040461 |
| 93 | glandular epithelial cell differentiation (GO:0002067) | 3.31930036 |
| 94 | regulation of memory T cell differentiation (GO:0043380) | 3.31825940 |
| 95 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.31805381 |
| 96 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.31276976 |
| 97 | regulation of mononuclear cell migration (GO:0071675) | 3.30984063 |
| 98 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 3.30936910 |
| 99 | regulation of apoptotic cell clearance (GO:2000425) | 3.28543716 |
| 100 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.28328093 |
| 101 | cytokine biosynthetic process (GO:0042089) | 3.25683410 |
| 102 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.24232958 |
| 103 | positive regulation of catenin import into nucleus (GO:0035413) | 3.23863209 |
| 104 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.21938176 |
| 105 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.21938176 |
| 106 | regulation of macrophage chemotaxis (GO:0010758) | 3.18875821 |
| 107 | protein N-linked glycosylation (GO:0006487) | 3.18418316 |
| 108 | response to unfolded protein (GO:0006986) | 3.16776002 |
| 109 | regulation of natural killer cell differentiation (GO:0032823) | 3.16212853 |
| 110 | nucleotide-sugar metabolic process (GO:0009225) | 3.15893035 |
| 111 | GDP-mannose metabolic process (GO:0019673) | 3.14400603 |
| 112 | positive regulation of protein localization to plasma membrane (GO:1903078) | 3.14007223 |
| 113 | glial cell proliferation (GO:0014009) | 3.13476775 |
| 114 | regulation of transforming growth factor beta production (GO:0071634) | 3.11812061 |
| 115 | zinc ion transport (GO:0006829) | 3.11162081 |
| 116 | fucosylation (GO:0036065) | 3.09010055 |
| 117 | response to topologically incorrect protein (GO:0035966) | 3.08668211 |
| 118 | cellular modified amino acid catabolic process (GO:0042219) | 3.07594631 |
| 119 | transcytosis (GO:0045056) | 3.07406676 |
| 120 | desmosome organization (GO:0002934) | 3.07059601 |
| 121 | fibroblast migration (GO:0010761) | 3.05811782 |
| 122 | positive regulation of metanephros development (GO:0072216) | 3.05208118 |
| 123 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.03720088 |
| 124 | regulation of water loss via skin (GO:0033561) | 3.03582138 |
| 125 | potassium ion homeostasis (GO:0055075) | 3.02886270 |
| 126 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.01871772 |
| 127 | lung vasculature development (GO:0060426) | 3.01771818 |
| 128 | peptide catabolic process (GO:0043171) | 3.01767007 |
| 129 | positive regulation of calcium ion import (GO:0090280) | 3.00345466 |
| 130 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.00006815 |
| 131 | ER overload response (GO:0006983) | 2.99073140 |
| 132 | chemosensory behavior (GO:0007635) | 2.98626480 |
| 133 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.98412603 |
| 134 | protein targeting to Golgi (GO:0000042) | 2.97336195 |
| 135 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.94628313 |
| 136 | pericardium development (GO:0060039) | 2.94004532 |
| 137 | galactose metabolic process (GO:0006012) | 2.93882609 |
| 138 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.92743864 |
| 139 | positive regulation of tissue remodeling (GO:0034105) | 2.91753983 |
| 140 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 2.91397208 |
| 141 | reverse cholesterol transport (GO:0043691) | 2.91047561 |
| 142 | positive regulation of circadian rhythm (GO:0042753) | 2.88690579 |
| 143 | monosaccharide catabolic process (GO:0046365) | 2.87566935 |
| 144 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.87510237 |
| 145 | actin filament depolymerization (GO:0030042) | 2.86175466 |
| 146 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.85045830 |
| 147 | sequestering of metal ion (GO:0051238) | 2.84936588 |
| 148 | 2-oxoglutarate metabolic process (GO:0006103) | 2.83393329 |
| 149 | cell volume homeostasis (GO:0006884) | 2.82649787 |
| 150 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.82090894 |
| 151 | molting cycle (GO:0042303) | 2.81872535 |
| 152 | hair cycle (GO:0042633) | 2.81872535 |
| 153 | lung cell differentiation (GO:0060479) | 2.81481889 |
| 154 | phosphatidylserine metabolic process (GO:0006658) | 2.80703074 |
| 155 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.79900065 |
| 156 | mammary gland alveolus development (GO:0060749) | 2.79036306 |
| 157 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.78755140 |
| 158 | endocrine hormone secretion (GO:0060986) | 2.78728311 |
| 159 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.77174716 |
| 160 | short-chain fatty acid metabolic process (GO:0046459) | 2.75902919 |
| 161 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.75689931 |
| 162 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.75483982 |
| 163 | positive regulation of neurological system process (GO:0031646) | 2.75026181 |
| 164 | positive regulation of macrophage differentiation (GO:0045651) | 2.72180424 |
| 165 | negative regulation of coagulation (GO:0050819) | 2.70431704 |
| 166 | cytokine metabolic process (GO:0042107) | 2.70024733 |
| 167 | acute inflammatory response (GO:0002526) | 2.68628942 |
| 168 | myelin assembly (GO:0032288) | 2.68457136 |
| 169 | substrate-dependent cell migration (GO:0006929) | 2.66555978 |
| 170 | regulation of metanephros development (GO:0072215) | 2.65297749 |
| 171 | regulation of intracellular pH (GO:0051453) | 2.63100234 |
| 172 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.62546923 |
| 173 | lymphocyte chemotaxis (GO:0048247) | 2.62506304 |
| 174 | lens fiber cell differentiation (GO:0070306) | 2.62329570 |
| 175 | positive regulation of neutrophil migration (GO:1902624) | 2.60067078 |
| 176 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.60067078 |
| 177 | coronary vasculature morphogenesis (GO:0060977) | 2.56128476 |
| 178 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.55975634 |
| 179 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.54778079 |
| 180 | negative regulation of metanephros development (GO:0072217) | 2.53499735 |
| 181 | regulation of cellular pH (GO:0030641) | 2.52173131 |
| 182 | regulation of interleukin-8 secretion (GO:2000482) | 2.51975945 |
| 183 | Rap protein signal transduction (GO:0032486) | 2.51830692 |
| 184 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.51764779 |
| 185 | chronic inflammatory response (GO:0002544) | 2.51446766 |
| 186 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.50867405 |
| 187 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.50736465 |
| 188 | leukocyte degranulation (GO:0043299) | 2.50391728 |
| 189 | monocyte chemotaxis (GO:0002548) | 2.48051043 |
| 190 | branching involved in prostate gland morphogenesis (GO:0060442) | 10.8076025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.86535733 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.90848513 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.34120751 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.30630976 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.20641696 |
| 6 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.13937290 |
| 7 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.10560294 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.03584215 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.89543341 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.86639030 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.79756507 |
| 12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.70499796 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.68530553 |
| 14 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.59935731 |
| 15 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.55043359 |
| 16 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.53283170 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.36613461 |
| 18 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.36048300 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.33949510 |
| 20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.30820234 |
| 21 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.30350998 |
| 22 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.30350998 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.22743438 |
| 24 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.17764142 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 2.17629999 |
| 26 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.14616916 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.13614628 |
| 28 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 2.08974077 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.06438687 |
| 30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.04357440 |
| 31 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.98441207 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.96063148 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.94152957 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.93937051 |
| 35 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.87194713 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.83331075 |
| 37 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.79868143 |
| 38 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.76551607 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68808991 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.67990543 |
| 41 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.67890649 |
| 42 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.67061582 |
| 43 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66561136 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.66063193 |
| 45 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.63063974 |
| 46 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.62548825 |
| 47 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.62343027 |
| 48 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62314105 |
| 49 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60107713 |
| 50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.60028601 |
| 51 | ATF3_27146783_Chip-Seq_COLON_Human | 1.58914967 |
| 52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.56190743 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56176536 |
| 54 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.53706359 |
| 55 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.48161896 |
| 56 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.48161896 |
| 57 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.48161896 |
| 58 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.47679976 |
| 59 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47391766 |
| 60 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.45760221 |
| 61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.44032336 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.42355263 |
| 63 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.41701516 |
| 64 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41639420 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39107599 |
| 66 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38638693 |
| 67 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.37985370 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.35596280 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34827666 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34198318 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34198318 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.32871062 |
| 73 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32740962 |
| 74 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.32137651 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32128151 |
| 76 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31589027 |
| 77 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.30398387 |
| 78 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.29569579 |
| 79 | CJUN_26792858_Chip-Seq_BT549_Human | 1.29061942 |
| 80 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.28849703 |
| 81 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.27672383 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26866911 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.23539299 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23526637 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22825167 |
| 86 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.21825041 |
| 87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21093815 |
| 88 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.17716576 |
| 89 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17432232 |
| 90 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.17195724 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15020326 |
| 92 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.11239696 |
| 93 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.08397825 |
| 94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08229241 |
| 95 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07896690 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.07697504 |
| 97 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.07639347 |
| 98 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.07436428 |
| 99 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07098991 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04060893 |
| 101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03654343 |
| 102 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02494901 |
| 103 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02247602 |
| 104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01334586 |
| 105 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00252311 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99627947 |
| 107 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98176994 |
| 108 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.97106053 |
| 109 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95789018 |
| 110 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95679263 |
| 111 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95095125 |
| 112 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94499268 |
| 113 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93893363 |
| 114 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.90504379 |
| 115 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.89820810 |
| 116 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88977639 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88798183 |
| 118 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.88407550 |
| 119 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.86009541 |
| 120 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.85796377 |
| 121 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85731384 |
| 122 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85680500 |
| 123 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84907983 |
| 124 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.84846850 |
| 125 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.83541052 |
| 126 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82482355 |
| 127 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.82415626 |
| 128 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.82089328 |
| 129 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.79561727 |
| 130 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.78832934 |
| 131 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76063374 |
| 132 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.72845748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 7.37825879 |
| 2 | MP0005310_abnormal_salivary_gland | 4.91039497 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 4.85488118 |
| 4 | MP0002166_altered_tumor_susceptibility | 4.56138946 |
| 5 | MP0000537_abnormal_urethra_morphology | 4.48956967 |
| 6 | MP0009840_abnormal_foam_cell | 4.32794213 |
| 7 | MP0003950_abnormal_plasma_membrane | 3.59834006 |
| 8 | MP0002006_tumorigenesis | 3.48458197 |
| 9 | MP0005647_abnormal_sex_gland | 3.20783594 |
| 10 | MP0010386_abnormal_urinary_bladder | 3.13218550 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 2.90985779 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.87842440 |
| 13 | MP0004043_abnormal_pH_regulation | 2.80944443 |
| 14 | MP0002163_abnormal_gland_morphology | 2.76100568 |
| 15 | MP0000613_abnormal_salivary_gland | 2.60925663 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.58659875 |
| 17 | MP0001873_stomach_inflammation | 2.41233134 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.37686200 |
| 19 | * MP0005023_abnormal_wound_healing | 2.18049484 |
| 20 | MP0005084_abnormal_gallbladder_morpholo | 2.17877133 |
| 21 | MP0006054_spinal_hemorrhage | 2.14563786 |
| 22 | MP0001765_abnormal_ion_homeostasis | 2.11767118 |
| 23 | MP0003724_increased_susceptibility_to | 2.04903905 |
| 24 | MP0009785_altered_susceptibility_to | 2.04098402 |
| 25 | MP0010678_abnormal_skin_adnexa | 2.02184948 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.97515752 |
| 27 | MP0000538_abnormal_urinary_bladder | 1.96643163 |
| 28 | MP0001756_abnormal_urination | 1.95966483 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.95411465 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.91812341 |
| 31 | MP0001984_abnormal_olfaction | 1.84066068 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.76021259 |
| 33 | MP0002277_abnormal_respiratory_mucosa | 1.71250238 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.68202856 |
| 35 | MP0003195_calcinosis | 1.68025037 |
| 36 | MP0002295_abnormal_pulmonary_circulatio | 1.67367491 |
| 37 | MP0005220_abnormal_exocrine_pancreas | 1.60825262 |
| 38 | MP0005379_endocrine/exocrine_gland_phen | 1.57484002 |
| 39 | MP0000685_abnormal_immune_system | 1.57450610 |
| 40 | MP0002928_abnormal_bile_duct | 1.57246441 |
| 41 | MP0000462_abnormal_digestive_system | 1.56005089 |
| 42 | MP0002009_preneoplasia | 1.53675717 |
| 43 | MP0004233_abnormal_muscle_weight | 1.52391184 |
| 44 | MP0008004_abnormal_stomach_pH | 1.51909928 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.50112914 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.49703491 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 1.48755965 |
| 48 | MP0002132_abnormal_respiratory_system | 1.44757005 |
| 49 | MP0003011_delayed_dark_adaptation | 1.34518683 |
| 50 | MP0009384_cardiac_valve_regurgitation | 1.33000225 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.32679083 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.32359244 |
| 53 | MP0000858_altered_metastatic_potential | 1.31271344 |
| 54 | MP0000604_amyloidosis | 1.28970216 |
| 55 | * MP0010155_abnormal_intestine_physiology | 1.24921684 |
| 56 | MP0003436_decreased_susceptibility_to | 1.23829864 |
| 57 | MP0002136_abnormal_kidney_physiology | 1.20993182 |
| 58 | * MP0002419_abnormal_innate_immunity | 1.20558094 |
| 59 | MP0000627_abnormal_mammary_gland | 1.20327631 |
| 60 | MP0002796_impaired_skin_barrier | 1.18207502 |
| 61 | MP0003045_fibrosis | 1.17304559 |
| 62 | MP0005332_abnormal_amino_acid | 1.16740081 |
| 63 | * MP0001845_abnormal_inflammatory_respons | 1.14175646 |
| 64 | MP0000490_abnormal_crypts_of | 1.13295411 |
| 65 | MP0003329_amyloid_beta_deposits | 1.10953881 |
| 66 | MP0004272_abnormal_basement_membrane | 1.10334228 |
| 67 | MP0005381_digestive/alimentary_phenotyp | 1.10145791 |
| 68 | MP0008872_abnormal_physiological_respon | 1.09468568 |
| 69 | MP0001790_abnormal_immune_system | 1.09116076 |
| 70 | MP0005387_immune_system_phenotype | 1.09116076 |
| 71 | MP0002909_abnormal_adrenal_gland | 1.08770893 |
| 72 | * MP0005025_abnormal_response_to | 1.07646967 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 1.06774668 |
| 74 | MP0001663_abnormal_digestive_system | 1.05671867 |
| 75 | MP0001533_abnormal_skeleton_physiology | 1.04619769 |
| 76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04100349 |
| 77 | MP0001853_heart_inflammation | 1.03690781 |
| 78 | MP0001664_abnormal_digestion | 1.02607776 |
| 79 | MP0000534_abnormal_ureter_morphology | 1.00340727 |
| 80 | MP0005275_abnormal_skin_tensile | 1.00140815 |
| 81 | MP0008438_abnormal_cutaneous_collagen | 0.99738553 |
| 82 | * MP0000477_abnormal_intestine_morphology | 0.98630512 |
| 83 | MP0001545_abnormal_hematopoietic_system | 0.97126741 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 0.97126741 |
| 85 | MP0003252_abnormal_bile_duct | 0.95431002 |
| 86 | MP0001299_abnormal_eye_distance/ | 0.93884894 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 0.92621453 |
| 88 | MP0004883_abnormal_blood_vessel | 0.92187509 |
| 89 | MP0002098_abnormal_vibrissa_morphology | 0.92182645 |
| 90 | * MP0002452_abnormal_antigen_presenting | 0.91978945 |
| 91 | MP0005085_abnormal_gallbladder_physiolo | 0.90438660 |
| 92 | MP0002060_abnormal_skin_morphology | 0.89106892 |
| 93 | MP0000566_synostosis | 0.89004796 |
| 94 | MP0001270_distended_abdomen | 0.87764568 |
| 95 | MP0004019_abnormal_vitamin_homeostasis | 0.87642056 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.87538805 |
| 97 | * MP0000343_altered_response_to | 0.86183432 |
| 98 | MP0005187_abnormal_penis_morphology | 0.84240753 |
| 99 | MP0001216_abnormal_epidermal_layer | 0.83876206 |
| 100 | MP0002896_abnormal_bone_mineralization | 0.83073361 |
| 101 | MP0002135_abnormal_kidney_morphology | 0.82418819 |
| 102 | MP0001485_abnormal_pinna_reflex | 0.82364384 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.81544831 |
| 104 | MP0003638_abnormal_response/metabolism_ | 0.81491948 |
| 105 | MP0005367_renal/urinary_system_phenotyp | 0.79870418 |
| 106 | MP0000516_abnormal_urinary_system | 0.79870418 |
| 107 | MP0000249_abnormal_blood_vessel | 0.78761197 |
| 108 | * MP0003866_abnormal_defecation | 0.78674658 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.77441207 |
| 110 | * MP0009764_decreased_sensitivity_to | 0.77422254 |
| 111 | MP0001944_abnormal_pancreas_morphology | 0.77322639 |
| 112 | MP0003315_abnormal_perineum_morphology | 0.76481955 |
| 113 | MP0002089_abnormal_postnatal_growth/wei | 0.74871737 |
| 114 | MP0000470_abnormal_stomach_morphology | 0.74680537 |
| 115 | MP0001881_abnormal_mammary_gland | 0.74664063 |
| 116 | MP0004782_abnormal_surfactant_physiolog | 0.74562654 |
| 117 | MP0008469_abnormal_protein_level | 0.74359263 |
| 118 | MP0001346_abnormal_lacrimal_gland | 0.73902862 |
| 119 | MP0005670_abnormal_white_adipose | 0.73817550 |
| 120 | * MP0003300_gastrointestinal_ulcer | 0.73440018 |
| 121 | MP0002933_joint_inflammation | 0.73188099 |
| 122 | MP0002168_other_aberrant_phenotype | 0.71409394 |
| 123 | MP0004947_skin_inflammation | 0.71150619 |
| 124 | MP0003936_abnormal_reproductive_system | 0.71134649 |
| 125 | MP0003186_abnormal_redox_activity | 0.69544267 |
| 126 | MP0005501_abnormal_skin_physiology | 0.69502196 |
| 127 | MP0001849_ear_inflammation | 0.69236468 |
| 128 | MP0005000_abnormal_immune_tolerance | 0.69083882 |
| 129 | MP0005164_abnormal_response_to | 0.68721146 |
| 130 | MP0003279_aneurysm | 0.68583546 |
| 131 | MP0005248_abnormal_Harderian_gland | 0.68507290 |
| 132 | MP0002254_reproductive_system_inflammat | 0.67874658 |
| 133 | MP0000230_abnormal_systemic_arterial | 0.67690828 |
| 134 | MP0004134_abnormal_chest_morphology | 0.67118263 |
| 135 | MP0002111_abnormal_tail_morphology | 0.67004611 |
| 136 | MP0005083_abnormal_biliary_tract | 0.66218461 |
| 137 | MP0003091_abnormal_cell_migration | 0.65278773 |
| 138 | MP0003890_abnormal_embryonic-extraembry | 0.64241308 |
| 139 | * MP0009765_abnormal_xenobiotic_induced | 0.64105105 |
| 140 | MP0005410_abnormal_fertilization | 0.63550076 |
| 141 | MP0000609_abnormal_liver_physiology | 0.63182900 |
| 142 | MP0003868_abnormal_feces_composition | 0.63003568 |
| 143 | MP0000377_abnormal_hair_follicle | 0.62371394 |
| 144 | MP0005408_hypopigmentation | 0.62136389 |
| 145 | MP0005365_abnormal_bile_salt | 0.60641010 |
| 146 | * MP0005166_decreased_susceptibility_to | 0.60069184 |
| 147 | MP0003075_altered_response_to | 0.59861468 |
| 148 | MP0000465_gastrointestinal_hemorrhage | 0.57362027 |
| 149 | MP0000762_abnormal_tongue_morphology | 0.56789164 |
| 150 | MP0005165_increased_susceptibility_to | 0.56120415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cochlea (HP:0000375) | 6.15326909 |
| 2 | Ileus (HP:0002595) | 5.81235208 |
| 3 | Aortic aneurysm (HP:0004942) | 4.58596883 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 4.28959123 |
| 5 | Abnormality of chloride homeostasis (HP:0011422) | 4.17992663 |
| 6 | Morphological abnormality of the inner ear (HP:0011390) | 4.05905778 |
| 7 | Micronodular cirrhosis (HP:0001413) | 3.96009010 |
| 8 | Abnormality of the right ventricle (HP:0001707) | 3.95928774 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.79444175 |
| 10 | Hydroxyprolinuria (HP:0003080) | 3.78354240 |
| 11 | Abnormality of proline metabolism (HP:0010907) | 3.78354240 |
| 12 | Steatorrhea (HP:0002570) | 3.68960002 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 3.62317331 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.60356411 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.60356411 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.60356411 |
| 17 | Malnutrition (HP:0004395) | 3.58561911 |
| 18 | Spondylolisthesis (HP:0003302) | 3.57733468 |
| 19 | Woolly hair (HP:0002224) | 3.56286307 |
| 20 | Azoospermia (HP:0000027) | 3.52042435 |
| 21 | Erythema (HP:0010783) | 3.49070138 |
| 22 | Onycholysis (HP:0001806) | 3.41154185 |
| 23 | Facial shape deformation (HP:0011334) | 3.39183900 |
| 24 | Potter facies (HP:0002009) | 3.39183900 |
| 25 | Rectal prolapse (HP:0002035) | 3.36039123 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.35042815 |
| 27 | Abnormal pancreas size (HP:0012094) | 3.32655358 |
| 28 | Increased CSF protein (HP:0002922) | 3.31944773 |
| 29 | Cone-rod dystrophy (HP:0000548) | 3.30450379 |
| 30 | Irregular vertebral endplates (HP:0003301) | 3.26447515 |
| 31 | Vascular tortuosity (HP:0004948) | 3.22635774 |
| 32 | Aortic dissection (HP:0002647) | 3.19607401 |
| 33 | Hypotrichosis (HP:0001006) | 3.15865508 |
| 34 | Fat malabsorption (HP:0002630) | 3.15616306 |
| 35 | Tetraparesis (HP:0002273) | 3.14219479 |
| 36 | Sparse eyelashes (HP:0000653) | 3.11066382 |
| 37 | Hypoplasia of the uterus (HP:0000013) | 3.07678055 |
| 38 | Pili torti (HP:0003777) | 3.07539563 |
| 39 | Subcapsular cataract (HP:0000523) | 3.06657062 |
| 40 | Late onset (HP:0003584) | 3.03891007 |
| 41 | Gout (HP:0001997) | 3.03002997 |
| 42 | Biliary tract neoplasm (HP:0100574) | 2.82198502 |
| 43 | Mitral stenosis (HP:0001718) | 2.79644845 |
| 44 | Abdominal distention (HP:0003270) | 2.79019935 |
| 45 | Subacute progressive viral hepatitis (HP:0006572) | 2.75411066 |
| 46 | Scotoma (HP:0000575) | 2.73684329 |
| 47 | Neonatal death (HP:0003811) | 2.72906769 |
| 48 | Abnormal biliary tract morphology (HP:0012440) | 2.70179051 |
| 49 | Abnormal foot bone ossification (HP:0010675) | 2.69350598 |
| 50 | Abnormality of the 2nd finger (HP:0004100) | 2.68349030 |
| 51 | Palpitations (HP:0001962) | 2.67902591 |
| 52 | Achilles tendon contracture (HP:0001771) | 2.67278171 |
| 53 | Petechiae (HP:0000967) | 2.65455495 |
| 54 | Portal hypertension (HP:0001409) | 2.59179385 |
| 55 | Stenosis of the external auditory canal (HP:0000402) | 2.58966219 |
| 56 | Congenital, generalized hypertrichosis (HP:0004540) | 2.57994592 |
| 57 | Parakeratosis (HP:0001036) | 2.57186668 |
| 58 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56840033 |
| 59 | Mucopolysacchariduria (HP:0008155) | 2.56840033 |
| 60 | Exocrine pancreatic insufficiency (HP:0001738) | 2.56034463 |
| 61 | Dysostosis multiplex (HP:0000943) | 2.54635234 |
| 62 | Hypothermia (HP:0002045) | 2.54272229 |
| 63 | Milia (HP:0001056) | 2.53059166 |
| 64 | Tubulointerstitial fibrosis (HP:0005576) | 2.51076155 |
| 65 | Hypoplasia of the pons (HP:0012110) | 2.50867476 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.50790384 |
| 67 | Aneurysm (HP:0002617) | 2.50333015 |
| 68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.49977577 |
| 69 | Hyperglycinuria (HP:0003108) | 2.49080798 |
| 70 | Ventricular tachycardia (HP:0004756) | 2.47834320 |
| 71 | Abnormality of the Achilles tendon (HP:0005109) | 2.47543140 |
| 72 | Radial bowing (HP:0002986) | 2.47044621 |
| 73 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.46282441 |
| 74 | Atrophic scars (HP:0001075) | 2.45934117 |
| 75 | Abnormality of the axillary hair (HP:0100134) | 2.45760638 |
| 76 | Abnormality of secondary sexual hair (HP:0009888) | 2.45760638 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.45259254 |
| 78 | Unilateral renal agenesis (HP:0000122) | 2.43145725 |
| 79 | Severe visual impairment (HP:0001141) | 2.42203190 |
| 80 | Fibular aplasia (HP:0002990) | 2.41178870 |
| 81 | Abnormality of the vertebral endplates (HP:0005106) | 2.40279862 |
| 82 | Increased purine levels (HP:0004368) | 2.40258823 |
| 83 | Hyperuricemia (HP:0002149) | 2.40258823 |
| 84 | Pustule (HP:0200039) | 2.38474031 |
| 85 | Recurrent pneumonia (HP:0006532) | 2.38196057 |
| 86 | Hypoplasia of dental enamel (HP:0006297) | 2.37814029 |
| 87 | Abnormality of the hepatic vasculature (HP:0006707) | 2.35066403 |
| 88 | Curly hair (HP:0002212) | 2.35034951 |
| 89 | Aplasia of the phalanges of the hand (HP:0009802) | 2.33809391 |
| 90 | Aplasia involving bones of the extremities (HP:0009825) | 2.33809391 |
| 91 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.33809391 |
| 92 | Dehydration (HP:0001944) | 2.33030877 |
| 93 | Male infertility (HP:0003251) | 2.32558293 |
| 94 | Focal segmental glomerulosclerosis (HP:0000097) | 2.30383267 |
| 95 | Central scotoma (HP:0000603) | 2.29286303 |
| 96 | Hand muscle atrophy (HP:0009130) | 2.28712382 |
| 97 | Widely patent fontanelles and sutures (HP:0004492) | 2.27419809 |
| 98 | Hypoplastic nipples (HP:0002557) | 2.25757569 |
| 99 | Abnormal hair laboratory examination (HP:0003328) | 2.24823579 |
| 100 | Thoracolumbar scoliosis (HP:0002944) | 2.24135989 |
| 101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22322362 |
| 102 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22322362 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22322362 |
| 104 | Slow-growing hair (HP:0002217) | 2.21352442 |
| 105 | Abnormality of hair growth rate (HP:0011363) | 2.21352442 |
| 106 | Abnormality of macrophages (HP:0004311) | 2.19628095 |
| 107 | Esophageal varix (HP:0002040) | 2.19166009 |
| 108 | Ureteral stenosis (HP:0000071) | 2.15684630 |
| 109 | Back pain (HP:0003418) | 2.15386481 |
| 110 | Abnormal spermatogenesis (HP:0008669) | 2.14993232 |
| 111 | Abnormality of the pons (HP:0007361) | 2.14088579 |
| 112 | Short hallux (HP:0010109) | 2.13415913 |
| 113 | Microretrognathia (HP:0000308) | 2.13005026 |
| 114 | Ureteral obstruction (HP:0006000) | 2.11763751 |
| 115 | Hematochezia (HP:0002573) | 2.10798568 |
| 116 | Polar cataract (HP:0010696) | 2.10674294 |
| 117 | Ulnar bowing (HP:0003031) | 2.10498276 |
| 118 | Glomerulonephritis (HP:0000099) | 2.10110933 |
| 119 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.08828867 |
| 120 | Coxa valga (HP:0002673) | 2.08242718 |
| 121 | Generalized aminoaciduria (HP:0002909) | 2.08193572 |
| 122 | Thrombocytosis (HP:0001894) | 2.06650719 |
| 123 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.06008522 |
| 124 | Abnormality of oral frenula (HP:0000190) | 2.04562561 |
| 125 | Arterial tortuosity (HP:0005116) | 2.03615913 |
| 126 | Spastic diplegia (HP:0001264) | 2.02937916 |
| 127 | Abnormal tarsal ossification (HP:0008369) | 2.01584808 |
| 128 | Gastrointestinal carcinoma (HP:0002672) | 2.00423893 |
| 129 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.00423893 |
| 130 | Alopecia of scalp (HP:0002293) | 2.00363201 |
| 131 | Nail dystrophy (HP:0008404) | 1.99827862 |
| 132 | Glomerulosclerosis (HP:0000096) | 1.99052288 |
| 133 | Interstitial pulmonary disease (HP:0006530) | 1.98590279 |
| 134 | Abnormality of macular pigmentation (HP:0008002) | 1.97845777 |
| 135 | Barrel-shaped chest (HP:0001552) | 1.96773333 |
| 136 | Tongue fasciculations (HP:0001308) | 1.96541582 |
| 137 | Plantar hyperkeratosis (HP:0007556) | 1.95965543 |
| 138 | Shawl scrotum (HP:0000049) | 1.95690285 |
| 139 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.95523821 |
| 140 | Tubulointerstitial abnormality (HP:0001969) | 1.95489862 |
| 141 | Osteomyelitis (HP:0002754) | 1.94254461 |
| 142 | Bowing of the arm (HP:0006488) | 1.92722167 |
| 143 | Bowed forearm bones (HP:0003956) | 1.92722167 |
| 144 | Hypoplastic labia majora (HP:0000059) | 1.92512118 |
| 145 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92473903 |
| 146 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.92052634 |
| 147 | Ankyloglossia (HP:0010296) | 1.91748506 |
| 148 | Beaking of vertebral bodies (HP:0004568) | 1.90417411 |
| 149 | Eczematoid dermatitis (HP:0000976) | 1.89966088 |
| 150 | Growth hormone excess (HP:0000845) | 1.88683746 |
| 151 | Distal upper limb amyotrophy (HP:0007149) | 1.88364862 |
| 152 | Upper limb amyotrophy (HP:0009129) | 1.88364862 |
| 153 | Aortic regurgitation (HP:0001659) | 1.87859172 |
| 154 | Pulmonary fibrosis (HP:0002206) | 1.87798909 |
| 155 | Facial diplegia (HP:0001349) | 1.87753803 |
| 156 | Glucose intolerance (HP:0000833) | 1.87458945 |
| 157 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.86364719 |
| 158 | Abnormality of glycine metabolism (HP:0010895) | 1.86364719 |
| 159 | Aplastic anemia (HP:0001915) | 1.86244188 |
| 160 | Hyperphosphatemia (HP:0002905) | 1.86110141 |
| 161 | Fragile nails (HP:0001808) | 1.85720505 |
| 162 | Abnormality of the gastric mucosa (HP:0004295) | 1.85303982 |
| 163 | Short humerus (HP:0005792) | 1.84332796 |
| 164 | Abnormal blistering of the skin (HP:0008066) | 1.83895332 |
| 165 | Vascular calcification (HP:0004934) | 1.82930940 |
| 166 | Metaphyseal irregularity (HP:0003025) | 1.82572926 |
| 167 | Cerebral palsy (HP:0100021) | 1.82000049 |
| 168 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.81445218 |
| 169 | Xanthomatosis (HP:0000991) | 1.79360756 |
| 170 | Abnormality of the intervertebral disk (HP:0005108) | 1.78082946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.82168327 |
| 2 | MST4 | 5.64604727 |
| 3 | EPHA2 | 5.47686111 |
| 4 | AKT3 | 4.78407807 |
| 5 | ERN1 | 3.70032618 |
| 6 | STK39 | 3.37466212 |
| 7 | SIK3 | 3.11339457 |
| 8 | STK24 | 3.00719469 |
| 9 | TAOK3 | 2.92550896 |
| 10 | LATS1 | 2.89823025 |
| 11 | EEF2K | 2.62712258 |
| 12 | TRIM28 | 2.37692304 |
| 13 | SCYL2 | 2.25608268 |
| 14 | MAP3K2 | 2.17528140 |
| 15 | LMTK2 | 2.16713192 |
| 16 | MYLK | 2.10472799 |
| 17 | RPS6KB2 | 2.02800400 |
| 18 | BCKDK | 1.95787907 |
| 19 | TTN | 1.94722519 |
| 20 | PRKG2 | 1.93216646 |
| 21 | OXSR1 | 1.85537149 |
| 22 | CDK8 | 1.72961160 |
| 23 | FER | 1.71442062 |
| 24 | LRRK2 | 1.63115036 |
| 25 | PTK6 | 1.59260039 |
| 26 | SIK1 | 1.53536698 |
| 27 | NUAK1 | 1.43368190 |
| 28 | BCR | 1.41513914 |
| 29 | MST1R | 1.39560085 |
| 30 | MAPKAPK3 | 1.37265098 |
| 31 | STK10 | 1.34238116 |
| 32 | STK38 | 1.33149127 |
| 33 | MAP2K2 | 1.28973031 |
| 34 | ZAK | 1.21099057 |
| 35 | PDK2 | 1.20517079 |
| 36 | TESK1 | 1.20088090 |
| 37 | ILK | 1.17799436 |
| 38 | TRIB3 | 1.01576388 |
| 39 | ERBB4 | 0.94769913 |
| 40 | MAP3K9 | 0.91488721 |
| 41 | PTK2 | 0.88355703 |
| 42 | DAPK1 | 0.83554168 |
| 43 | MET | 0.83313542 |
| 44 | PRKCI | 0.82747568 |
| 45 | MAP3K3 | 0.82700511 |
| 46 | IKBKB | 0.82231097 |
| 47 | IRAK3 | 0.81881419 |
| 48 | RIPK1 | 0.81223756 |
| 49 | PIK3CA | 0.78038188 |
| 50 | TESK2 | 0.76649137 |
| 51 | PDGFRA | 0.74152127 |
| 52 | PAK4 | 0.73928094 |
| 53 | JAK3 | 0.71575480 |
| 54 | CDC42BPA | 0.65804396 |
| 55 | DMPK | 0.64934511 |
| 56 | CDK9 | 0.63444711 |
| 57 | PKN2 | 0.63372120 |
| 58 | ROCK2 | 0.60176004 |
| 59 | PIK3CG | 0.60090106 |
| 60 | STK3 | 0.59460323 |
| 61 | KSR2 | 0.57877616 |
| 62 | MAP3K8 | 0.55470341 |
| 63 | NTRK1 | 0.54666662 |
| 64 | PAK2 | 0.52962820 |
| 65 | MAP3K12 | 0.51910295 |
| 66 | MAP2K1 | 0.50406827 |
| 67 | EPHB1 | 0.49857094 |
| 68 | PAK3 | 0.49516218 |
| 69 | NLK | 0.49378655 |
| 70 | DDR2 | 0.48589063 |
| 71 | TNK2 | 0.47514108 |
| 72 | FGFR2 | 0.47110840 |
| 73 | ROCK1 | 0.47091527 |
| 74 | TRPM7 | 0.46952300 |
| 75 | NME1 | 0.46346471 |
| 76 | EPHA3 | 0.45815663 |
| 77 | DAPK3 | 0.45799580 |
| 78 | JAK2 | 0.45798767 |
| 79 | MAP3K14 | 0.45066528 |
| 80 | RPS6KA2 | 0.44416817 |
| 81 | MELK | 0.40962098 |
| 82 | HIPK2 | 0.40456414 |
| 83 | LIMK1 | 0.39107275 |
| 84 | EIF2AK3 | 0.38944142 |
| 85 | EPHB2 | 0.38806205 |
| 86 | MKNK2 | 0.37276663 |
| 87 | KSR1 | 0.36047783 |
| 88 | CAMK2G | 0.35229026 |
| 89 | MARK2 | 0.34624012 |
| 90 | JAK1 | 0.33276539 |
| 91 | TGFBR2 | 0.33231796 |
| 92 | ERBB3 | 0.32173728 |
| 93 | CAMK2B | 0.31427468 |
| 94 | MAP3K7 | 0.31005572 |
| 95 | MATK | 0.30822001 |
| 96 | NEK6 | 0.30284394 |
| 97 | TYK2 | 0.29845025 |
| 98 | CAMK2D | 0.28675578 |
| 99 | MINK1 | 0.27798937 |
| 100 | ERBB2 | 0.27747798 |
| 101 | BMPR1B | 0.26971979 |
| 102 | CHUK | 0.25870027 |
| 103 | BRSK2 | 0.25125936 |
| 104 | MAP3K1 | 0.24185757 |
| 105 | EGFR | 0.23939323 |
| 106 | CSK | 0.23849381 |
| 107 | NEK9 | 0.23701130 |
| 108 | PRKCQ | 0.23611066 |
| 109 | TNIK | 0.23583611 |
| 110 | CSF1R | 0.23145432 |
| 111 | NME2 | 0.22310126 |
| 112 | IKBKE | 0.22094909 |
| 113 | FYN | 0.21977544 |
| 114 | DAPK2 | 0.21544467 |
| 115 | MTOR | 0.21155914 |
| 116 | INSRR | 0.20618758 |
| 117 | TGFBR1 | 0.20364139 |
| 118 | GSK3A | 0.20021305 |
| 119 | PDK3 | 0.19611043 |
| 120 | PDK4 | 0.19611043 |
| 121 | GRK1 | 0.19096668 |
| 122 | CSNK1A1L | 0.18592103 |
| 123 | CASK | 0.17242774 |
| 124 | SRC | 0.17223766 |
| 125 | PIM2 | 0.16833246 |
| 126 | ABL1 | 0.16732967 |
| 127 | INSR | 0.16545374 |
| 128 | TBK1 | 0.16540811 |
| 129 | PDPK1 | 0.16152561 |
| 130 | PDK1 | 0.15563771 |
| 131 | BMX | 0.15065088 |
| 132 | PDGFRB | 0.15010064 |
| 133 | AKT2 | 0.14596479 |
| 134 | PRKCE | 0.13982266 |
| 135 | LATS2 | 0.12620627 |
| 136 | RET | 0.12032273 |
| 137 | RPS6KL1 | 0.11709317 |
| 138 | RPS6KC1 | 0.11709317 |
| 139 | CSNK1G3 | 0.10957369 |
| 140 | CDK6 | 0.10931179 |
| 141 | CSNK1A1 | 0.10830250 |
| 142 | STK38L | 0.10421210 |
| 143 | PRKCZ | 0.10279159 |
| 144 | FGFR1 | 0.10231686 |
| 145 | PRKCG | 0.08992768 |
| 146 | ADRBK2 | 0.08681948 |
| 147 | ICK | 0.08551891 |
| 148 | IGF1R | 0.08187769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.26688534 |
| 2 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 4.20794271 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.79158047 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.03418287 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.84199871 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.56796055 |
| 7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.51613433 |
| 8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.41315436 |
| 9 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.33667630 |
| 10 | Tight junction_Homo sapiens_hsa04530 | 2.11398105 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02027001 |
| 12 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.78463946 |
| 13 | Bladder cancer_Homo sapiens_hsa05219 | 1.76121215 |
| 14 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.72849285 |
| 15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.71499664 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.64350878 |
| 17 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.64171327 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.61846321 |
| 19 | Adherens junction_Homo sapiens_hsa04520 | 1.61311646 |
| 20 | Prostate cancer_Homo sapiens_hsa05215 | 1.60399787 |
| 21 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.46660985 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.45579589 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.45389777 |
| 24 | Endometrial cancer_Homo sapiens_hsa05213 | 1.45151546 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.37867976 |
| 26 | Amoebiasis_Homo sapiens_hsa05146 | 1.35630803 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35024593 |
| 28 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.31809933 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.31579938 |
| 30 | Hepatitis C_Homo sapiens_hsa05160 | 1.30994381 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.30795059 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.23276907 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.20352638 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19501517 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17875469 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.17692499 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17438956 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14069339 |
| 39 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.13939330 |
| 40 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.12830023 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.12814638 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 1.10278292 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.07358184 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07026489 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.05631441 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05024976 |
| 47 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.04749170 |
| 48 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.04234020 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03418299 |
| 50 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.03288425 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 1.01373930 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99875212 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99651975 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 0.98925805 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.97421459 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91573201 |
| 57 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.90184002 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.88327137 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87963361 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87559081 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86084572 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85502385 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.85474417 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85453628 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82513078 |
| 66 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.81100077 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80722399 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80609308 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80578590 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80326317 |
| 71 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79192188 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79154918 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77345824 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76724664 |
| 75 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75436143 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74936722 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74730834 |
| 78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74315081 |
| 79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74304951 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73956683 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73945282 |
| 82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72827223 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72547761 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.71300397 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.70646504 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70559248 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70294215 |
| 88 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.67399895 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66071700 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64968705 |
| 91 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.64841051 |
| 92 | Pathways in cancer_Homo sapiens_hsa05200 | 0.63768515 |
| 93 | Melanoma_Homo sapiens_hsa05218 | 0.63698024 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61248156 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61211698 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60996275 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60666983 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.60412852 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60319802 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59895001 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59342765 |
| 102 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.58846423 |
| 103 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58778277 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.57498902 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57386649 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.55824605 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55774902 |
| 108 | Bile secretion_Homo sapiens_hsa04976 | 0.54793891 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54206913 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51782176 |
| 111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51499545 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49647703 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49490008 |
| 114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48980072 |
| 115 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48716792 |
| 116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47878467 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47177827 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44645131 |
| 119 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.43813290 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43017668 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.42968599 |
| 122 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41895445 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41571209 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.40727090 |
| 125 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40563925 |
| 126 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39206512 |
| 127 | Influenza A_Homo sapiens_hsa05164 | 0.39079039 |
| 128 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38953471 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38085527 |
| 130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37724189 |
| 131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37006511 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36658231 |
| 133 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36395643 |
| 134 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.36334372 |
| 135 | Gap junction_Homo sapiens_hsa04540 | 0.35558565 |
| 136 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.35209104 |
| 137 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33435782 |
| 138 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32970690 |
| 139 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.32892818 |
| 140 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32431434 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32163437 |
| 142 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31599103 |
| 143 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.31523504 |
| 144 | Prion diseases_Homo sapiens_hsa05020 | 0.31458483 |
| 145 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29749168 |
| 146 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29184397 |
| 147 | Platelet activation_Homo sapiens_hsa04611 | 0.29007975 |
| 148 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.28313053 |

